Research
Hormonal
Injectable subcutaneous medications like semaglutide are gaining popularity for weight loss.
Practitioners should be aware of the increasing use of these medications for weight loss.
StrongSupportsmedium confidence
Injectable subcutaneous medications initially designed for use in type 2 diabetes management, such as semaglutide and other glucagon-like peptide-1 receptor agonists, are rapidly gaining popularity for their effects on weight.
Why this rating
The claim is based on a broad observation of medication use.
Source
Injectable Weight Loss Medications in Plastic Surgery: What We Know, Perioperative Considerations, and Recommendations for the Future
Elizabeth S. O’Neill et al. · Plastic & Reconstructive Surgery Global Open · 2024
reviewCited 33×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →